RESUMO
Atherosclerosis is an inflammatory-fibroproliferative response of the arterial wall involving a complex set of interconnected events where cell proliferation (lymphomonocytes, and endothelial and smooth-muscle cells) and substantial perturbations of intracellular cholesterol metabolism are considered to be among the main features. Glucose-6-phosphate dehydrogenase (G6PD), the key enzyme of the hexose-monophosphate shunt pathway, is an essential enzyme involved in both cell growth and cholesterol metabolism, raising the question as to whether G6PD deficiency may have metabolic and growth implications in a deficient population. In the present study, we investigated cell growth and cholesterol metabolism in peripheral blood lymphomononuclear cells (PBMC) from G6PD-normal (n = 5) and -deficient (n = 5) subjects stimulated with lectins (phytohaemoagglutinin and Concanavalin A). G6PD activity, DNA ([3H]-thymidine incorporation) cholesterol synthesis and esterification ([14C]-acetate and [14C]-oleate incorporation), and G6PD, HMGCoA reductase and low density lipoprotein (LDL) receptor mRNA levels (RT-PCR) all increased following lectin stimulation in both normal and G6PD-deficient cells. However, these parameters were significantly lower in G6PD-deficient cells (P < 0.05). It is of interest that G6PD-deficient PBMC, which showed lower expression of G6PD and higher expression of the LDL receptor gene than normal PBMC under basal conditions, exhibited an opposite pattern after stimulation: G6PD and HMGCoA reductase being expressed at significantly higher levels in deficient than in normal cells (P < 0.05). We conclude that the reduced capability of G6PD-deficient cells to respond to mitogenic stimuli and to synthesize cholesterol esters may represent favourable conditions for reducing the risk of cardiovascular diseases.
Assuntos
Colesterol/metabolismo , Deficiência de Glucosefosfato Desidrogenase/enzimologia , Deficiência de Glucosefosfato Desidrogenase/metabolismo , Leucócitos Mononucleares/enzimologia , Leucócitos Mononucleares/metabolismo , Adulto , Arteriosclerose/etiologia , Divisão Celular , Células Cultivadas , DNA/biossíntese , Glucosefosfato Desidrogenase/genética , Glucosefosfato Desidrogenase/metabolismo , Deficiência de Glucosefosfato Desidrogenase/genética , Humanos , Hidroximetilglutaril-CoA Redutases/biossíntese , Hidroximetilglutaril-CoA Redutases/genética , Cinética , Lipídeos/sangue , Masculino , RNA Mensageiro/biossíntese , Receptores de LDL/biossíntese , Receptores de LDL/genéticaRESUMO
A positive correlation between cholesterol esterification and growth rate potential was previously found in our laboratory during the growth of CEM and MOLT4 lymphoblastic cells. In the current study, we investigated whether the rates of cholesterol esters synthesis correlate with changes of acyl-CoAcholesterol acyltransferase (ACAT) mRNA levels and of other genes implied in cholesterol biosynthesis and uptake, such as 3-hydroxy-3-methylglutaryl-CoA (HMGCoA) reductase and low density lipoprotein (LDL) receptor. The results showed that the more rapid growing CEM cells had lower levels of expression of HMGCoA-reductase and LDL receptors compared to MOLT4. By contrast, ACAT mRNA levels were higher in CEM cells, further supporting the concept of a possible involvement of cholesterol esters in the regulation of cell growth and division. In this study, high levels of cholesterol esterification and of expression of ACAT gene were also associated with a markedly increased expression of multidrug resistance (MDR1) gene, suggesting that MDR1 activity might contribute to regulate the rate of cell growth and division by modulating intracellular cholesterol ester levels.
Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP/genética , Ésteres do Colesterol/metabolismo , Leucemia de Células T , Animais , Divisão Celular/fisiologia , Colesterol/biossíntese , Primers do DNA , Regulação Enzimológica da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Humanos , Hidroximetilglutaril-CoA Redutases/genética , Hidroximetilglutaril-CoA Redutases/metabolismo , Camundongos , RNA Mensageiro/análise , Receptores de LDL/genética , Receptores de LDL/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Esterol O-Aciltransferase/genética , Esterol O-Aciltransferase/metabolismo , Células Tumorais Cultivadas/química , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/enzimologiaRESUMO
The activity of glucose-6-phosphate dehydrogenase (G6PD), the key enzyme of the hexose monophosphate (HMP) shunt pathway, was measured in both normal and tumoral larynx tissues from normal and G6PD deficient subjects. Significant increases of this enzymatic activity were found in tumoral tissues of both normal and G6PD deficient subjects, who were characterized by very low levels of G6PD activity in erythrocytes as well as in larynx tissue.
Assuntos
Carcinoma/enzimologia , Deficiência de Glucosefosfato Desidrogenase/enzimologia , Glucosefosfato Desidrogenase/metabolismo , Neoplasias Laríngeas/enzimologia , Idoso , Eritrócitos/enzimologia , Feminino , Humanos , Laringe/enzimologia , Masculino , Pessoa de Meia-IdadeRESUMO
In the present study we examined gene expression and glucose-6-phosphate dehydrogenase (G6PD) activity in leukemic cells isolated from G6PD normal and deficient subjects. The results have shown that G6PD activity strongly increases in G6PD normal leukemic cells as well as in G6PD deficient leukemic cells when compared to peripheral blood mononuclear cells (PBMC). Higher levels of G6PD gene expression were observed in leukemic cells from G6PD deficient patients compared to G6PD normal. A similar pattern of gene expression was also observed for 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase. These results support the hypothesis that G6PD deficient cell, in order to sustain their growth, must respond to the low activity of their mutant enzyme with an increase in quantity through an induction of gene expression.
Assuntos
Expressão Gênica , Deficiência de Glucosefosfato Desidrogenase/enzimologia , Glucosefosfato Desidrogenase/metabolismo , Leucemia/enzimologia , Adulto , Células Cultivadas , Humanos , Hidroximetilglutaril-CoA Redutases/metabolismo , Leucemia/metabolismo , Leucócitos Mononucleares/enzimologia , Leucócitos Mononucleares/metabolismo , Masculino , Reação em Cadeia da Polimerase , RNA Mensageiro/metabolismo , Receptores de LDL/metabolismoRESUMO
In this study serum cholesterol was measured in different types of human hematologic malignancies characterized by a wide range of cell proliferation. In all tumoral types a significant decrease of HDL cholesterol was observed, whereas total serum cholesterol generally remained unchanged. Another interesting observation of our study was the apparent inverse correlation between the extent of cell proliferation in these neoplastic disorders and the level of HDL cholesterol. Since a decrease of HDL cholesterol was previously observed, in our laboratory, in different experimental models of normal and neoplastic cell proliferation, we suggest that the decrease of HDL cholesterol may be a generalized phenomenon related to massive cellular growth in normal and malignant processes.
Assuntos
HDL-Colesterol/sangue , Colesterol/sangue , Doenças Hematológicas/sangue , Neoplasias/sangue , Adulto , Idoso , Idoso de 80 Anos ou mais , Humanos , Pessoa de Meia-IdadeRESUMO
DNA synthesis, cholesterogenesis and the enzymes of the hexosemonophosphate (HMP) shunt pathway were investigated in liver of diabetic rats treated with insulin and in fasted/re-fed rats. Both insulin and refeeding were found to induce liver cell proliferation, accompanied by a remarkable increase in cholesterogenesis. An enhancement of glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (G6PD) activities was also found in insulin-treated diabetic rats and in re-fed rats, supporting the concept that these two enzymes are involved in the proliferative process. Since insulin did not exert the same biochemical effects in a non replicating cell population, such as in insulin-treated normal rats, these studies provide new evidence of a close correlation between DNA, cholesterol synthesis and HMP shunt enzymes during cell proliferation.
Assuntos
Colesterol/biossíntese , DNA/biossíntese , Diabetes Mellitus Experimental/metabolismo , Insulina/farmacologia , Via de Pentose Fosfato/efeitos dos fármacos , Animais , Divisão Celular/efeitos dos fármacos , Diabetes Mellitus Experimental/patologia , Jejum , Fígado/citologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Ratos , Ratos EndogâmicosRESUMO
Wistar rats treated with lead nitrate were used in these experiments to provide evidence of the possible correlation between hyperplasia, induced cholesterol synthesis and the levels of glucose-6-phosphate dehydrogenase (G-6-PD) in the liver. Lead treatment increases liver weight, hepatic cholesterol esters and the relative content of free cholesterol. An increase of the incorporation of tritiated water in free and cholesterol esters was also observed. The effect of lead resulted in an increase of hepatic G-6-PD at all times considered. The correlation between these parameters and hyperplasia are discussed.
Assuntos
Colesterol/biossíntese , Chumbo/farmacologia , Fígado/patologia , Nitratos/farmacologia , Animais , Colesterol/sangue , Ésteres do Colesterol/metabolismo , Glucosefosfato Desidrogenase/metabolismo , Hiperplasia/induzido quimicamente , Fígado/metabolismo , Masculino , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos EndogâmicosRESUMO
Previous studies from the authors' laboratories have shown that cancer patients are characterized by lower levels of high-density lipoprotein cholesterol (HDL-C) compared with those of normal subjects. HDLs are a complex class of lipoproteins which can be divided mainly into two categories, HDL2 and HDL3, that have not only different lipid and protein composition but also different functions. Therefore, for a better understanding of the metabolism of HDL during tumour growth, the different subfractions of HDL (HDL2 and HDL3) were analysed in the serum of neoplastic patients using a rapid and simple high-performance liquid chromatography (HPLC) method for the analysis. The results obtained showed that serum from neoplastic patients exhibits a peculiar pattern in the distribution of HDL subfractions, consisting of a sharp decrease in HDL3 and a consequent increase of the normal HDL2/HDL3 ratio. It is suggested that evaluation of the HDL subfractions may be of clinical relevance for cancer status and that due to its simplicity, short analytical time and small sample volume required, the HPLC technique used in this study can be easily applied to routine analysis in cancer patients.
Assuntos
Lipoproteínas HDL/sangue , Lipoproteínas HDL/isolamento & purificação , Neoplasias/sangue , Adulto , Idoso , Feminino , Humanos , Lipoproteínas HDL2 , Lipoproteínas HDL3 , Lipoproteínas LDL/sangue , Lipoproteínas LDL/isolamento & purificação , Lipoproteínas VLDL/sangue , Lipoproteínas VLDL/isolamento & purificação , Masculino , Pessoa de Meia-Idade , Valores de ReferênciaRESUMO
The effect of 3-methylcholanthrene (3-MC), an inducer of the mixed function oxidases system (MFOS), was investigated in male Wistar rats in relation to plasmatic cholesterol and hepatic glucose-6-phosphate dehydrogenase (G-6-PD). 3-MC induced an increase in total cholesterol; the maximal increase was seen 2 days after treatment (50%). The increase in total cholesterol was followed by an augmentation in cholesterol HDL. 3-MC treatment resulted also in an increase of hepatic G-6-PD.
Assuntos
Colesterol/sangue , Glucosefosfato Desidrogenase/metabolismo , Fígado/enzimologia , Metilcolantreno/farmacologia , Animais , HDL-Colesterol , Lipoproteínas HDL/sangue , Fígado/efeitos dos fármacos , Masculino , Ratos , Ratos EndogâmicosRESUMO
In the present study, lipoprotein metabolism was investigated during compensatory hyperplasia of bone marrow after haemolysis induced by phenylhydrazine (20 mg/kg b.w.) administration in rats. The rats were sacrificed at different time intervals (0, 1, 2 and 5 days) after phenylhydrazine treatment. Analysis of the different fractions of lipoproteins has shown that during bone marrow hyperplasia there is an alteration of lipoprotein profiles, mainly due to a decrease of HDL2 and HDL3 subfractions.
Assuntos
Medula Óssea/patologia , HDL-Colesterol/sangue , Animais , Hemólise/efeitos dos fármacos , Hiperplasia/sangue , Masculino , Fenil-Hidrazinas , Ratos , Ratos EndogâmicosRESUMO
DNA and cholesterol synthesis were investigated in the kidneys of fasted-refed rats. Refeeding resulted in an increase in kidney DNA synthesis, as measured by 3H-thymidine incorporation, starting at 72 h. The increase in DNA synthesis was accompanied by a stimulation of cholesterol synthesis, as measured by 14C-acetate incorporation into cholesterol.
Assuntos
Colesterol/biossíntese , DNA/biossíntese , Ingestão de Alimentos , Rim/metabolismo , Animais , Jejum , Masculino , Ratos , Ratos EndogâmicosRESUMO
Previous studies by our laboratory have shown that lead nitrate when injected intravenously as a single dose to rats, induces a hyperplastic response in the liver. Liver hyperplasia was accompanied by an increase in cholesterol synthesis, an accumulation of cholesterol esters and by a stimulation of hexose-monophosphate (HMP) shunt enzyme activities. In the present report, hepatic DNA, mitotic index, cholesterol metabolism, as well as glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (6PGD) activities, were investigated during liver hyperplasia induced by lead in fasted rats. Fasting was chosen as an experimental model characterized by a very strong depression of those metabolic pathways (cholesterol synthesis and HMP shunt) that we have found related to liver hyperplasia. The mitogenic response, even if at minor extent, also occurs in liver of fasted rats. A stimulation of cholesterol synthesis and HMP shunt enzyme activities, was also observed in lead-treated fasted rats, adding further support to the fact that an endogenous source of newly synthesized cholesterol together with a suitable increase of HMP shunt enzyme activities is needed during hepatic cell proliferation.
Assuntos
Colesterol/biossíntese , DNA/biossíntese , Jejum , Fígado/patologia , Animais , Glucosefosfato Desidrogenase/análise , Hiperplasia/induzido quimicamente , Hiperplasia/enzimologia , Chumbo , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Índice Mitótico/efeitos dos fármacos , Nitratos , Tamanho do Órgão/efeitos dos fármacos , Fosfogluconato Desidrogenase/análise , Ratos , Ratos EndogâmicosRESUMO
In the present study the three dimeric molecular forms of rat liver glucose-6-phosphate dehydrogenase were investigated during liver hyperplasia induced by lead nitrate. An increase of band 3 and a concomitant decrease of band 1 was found, indicating that this proliferating process is characterized by a peculiar pattern in the distribution of liver G6PD activity. Since the same pattern was observed also in liver hyperplasia induced in fasted animals, a condition otherwise characterized by a shift towards band 1, we suggest that during proliferating processes the metabolic control normally exerted by fasting on the enzymatic activity is overcome.
Assuntos
Glucosefosfato Desidrogenase/metabolismo , Isoenzimas/metabolismo , Chumbo/toxicidade , Fígado/patologia , Nitratos/toxicidade , Animais , Eletroforese em Gel de Poliacrilamida , Jejum/metabolismo , Hiperplasia/induzido quimicamente , Masculino , Ratos , Ratos EndogâmicosRESUMO
Liver regeneration after partial hepatectomy was used as an experimental model for studying mammalian cell division and replication. The rate of cell proliferation in this hyperplastic model was correlated with hepatic de novo synthesis of cholesterol, with the hexose monophosphate shunt pathway of glucose metabolism, and with serum lipoproteins. An increase of hepatic cholesterol esters and of incorporation of tritiated water in cholesterol esters was observed at 24 hr after partial hepatectomy. Partial hepatectomy also resulted in an increase of hepatic glucose-6-phosphate dehydrogenase and in alteration of serum lipoproteins, primarily due to a selective decline in high density lipoprotein fraction.
Assuntos
Colesterol/biossíntese , Glucosefosfato Desidrogenase/metabolismo , Lipoproteínas/sangue , Regeneração Hepática , Fígado/metabolismo , Colesterol/sangue , Cromatografia Líquida de Alta Pressão , Hepatectomia , Lipoproteínas HDL/sangue , Fígado/enzimologia , MasculinoRESUMO
Sardinian males with erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency have lower serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (ApoB), compared to normals. Since the enzyme deficiency is expressed also in nucleated cells, we studied cholesterol (C) and DNA synthesis and LDL-receptor expression in freshly isolated circulating mononuclear cells from normal and G-6-PD-deficient Sardinians. Synthesis of C (as 14C-acetate incorporation) and of DNA (as 3H-thymidine incorporation) was clearly reduced, both in basal state and after PHA stimulation, in G-6-PD-deficient cells compared to normal cells. On the other hand, no clear influence of G-6-PD deficiency on LDL-receptor expression could be demonstrated. The Mediterranean variant of G-6-PD deficiency is characterized, whatever the metabolic mechanism may be, by a serum lipoprotein pattern of reduced atherogenicity.
Assuntos
Apolipoproteínas B/sangue , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Doença das Coronárias/etiologia , Eritrócitos/metabolismo , Deficiência de Glucosefosfato Desidrogenase/metabolismo , Linfócitos/metabolismo , Receptores de LDL/metabolismo , Adulto , Apolipoproteínas B/genética , HDL-Colesterol/genética , LDL-Colesterol/genética , DNA/biossíntese , Eritrócitos/enzimologia , Feminino , Deficiência de Glucosefosfato Desidrogenase/sangue , Deficiência de Glucosefosfato Desidrogenase/complicações , Deficiência de Glucosefosfato Desidrogenase/genética , Heterozigoto , Homozigoto , Humanos , Itália , Linfócitos/enzimologia , Masculino , Pessoa de Meia-Idade , Receptores de LDL/genética , Fatores de RiscoRESUMO
Glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate, dehydrogenase the key enzymes of the hexose monophosphate shunt pathway, were measured in both surrounding and tumoral lung tissues from normal and G6PD-deficient subjects. A significant increase of these enzymatic activities in tumoral tissue was found not only in G6PD-normal patients, but also in G6PD-deficient patients with very low or nonmeasurable G6PD activity in both erythrocytes and normal lung tissue.
Assuntos
Deficiência de Glucosefosfato Desidrogenase/enzimologia , Glucosefosfato Desidrogenase/análise , Neoplasias Pulmonares/enzimologia , Via de Pentose Fosfato , Fosfogluconato Desidrogenase/análise , Adulto , Idoso , Eritrócitos/enzimologia , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Sexual dimorphism exists in the response of rats to lead nitrate, liver hyperplasia occuring earlier and being more pronounced in males. Excess dietary choline in females shifted the growth pattern towards that of males. To determine whether phosphatidylcholine-induced growth modulations could be related to a derangement of cholesterol metabolism, liver accumulation of cholesterol esters and plasma lipoprotein patterns were investigated. In males, lead-induced liver hyperplasia was associated with increased total cholesterol hepatic content, accumulated cholesterol esters and reduced concentration of plasma High Density Lipoprotein (HDL) cholesterol. Females were less responsive to the liver mitogenic signal of lead nitrate; there was no elevation of cholesterol content nor any marked accumulation of cholesterol esters. This is consistent with the lack of change in the plasma levels of HDL cholesterol. Continuous choline feeding displaced the liver cholesterol ester pattern and plasma HDL cholesterol levels in females, and in parallel that of DNA synthesis, towards those of males. Choline was not observed to have any effect in males. These results suggest that the derangement of phosphatidylcholine metabolism induces growth-related changes in cholesterol turnover; they are consistent with the proposal that the intracellular content of cholesterol esters may have a role in regulating liver growth rates.
Assuntos
Ésteres do Colesterol/metabolismo , Colina/farmacologia , Lipoproteínas HDL/sangue , Fígado/patologia , Animais , Feminino , Hiperplasia/induzido quimicamente , Hiperplasia/metabolismo , Chumbo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Nitratos , Ratos , Ratos Wistar , Caracteres SexuaisRESUMO
The livers of streptozotocin-induced diabetic and fasted rats showed a decreased cholesterol synthesis measured by in vitro incorporation of [2-14C]acetate. A significant decrease of glucose-6-phosphate dehydrogenase (G-6-PD), 6-phosphogluconate dehydrogenase (6-PGD), and pyruvate kinase (PK) was also observed 7 days after administration of streptozotocin. These enzymatic activities were also low in livers of 72 hr fasted animals. An increase of glucose-6-phosphatase (G-6-Pase) was observed consistently in diabetic as well as in fasted rats. Suitable amounts of insulin and refeeding normalized the alterated enzymatic activities in diabetic and in fasted animals, respectively.
Assuntos
Colesterol/biossíntese , Diabetes Mellitus Experimental/metabolismo , Jejum , Fígado/metabolismo , Via de Pentose Fosfato , Animais , Glucose-6-Fosfatase/metabolismo , Insulina/farmacologia , Masculino , Ratos , Ratos EndogâmicosRESUMO
Lead nitrate when injected intravenously as a single dose to male Wistar rats causes a strong hepatic proliferative response followed by reabsorption of excess tissue within 10-14 days. The rate of cell proliferation in this hyperplastic model was positively correlated with hepatic de novo synthesis of cholesterol, stimulation of the hexose monophosphate shunt pathway of glucose metabolism and with alterations in serum lipoproteins.
Assuntos
Colesterol/sangue , Intoxicação por Chumbo/sangue , Chumbo/toxicidade , Fígado/efeitos dos fármacos , Animais , Divisão Celular/efeitos dos fármacos , Glucosefosfato Desidrogenase/biossíntese , Hiperplasia/sangue , Hiperplasia/induzido quimicamente , Injeções Intravenosas , Chumbo/administração & dosagem , Intoxicação por Chumbo/patologia , Fígado/metabolismo , Fígado/patologia , Masculino , Tamanho do Órgão/efeitos dos fármacos , Fosfatidilcolina-Esterol O-Aciltransferase/biossíntese , Ratos , Ratos WistarRESUMO
The effect of phenobarbital treatment on HDL cholesterol was studied in male and female Wister rats. An increase of HDL cholesterol was observed in both sexes one day after the administration of the barbiturate. The values of HDL cholesterol returned to those of the control animals l7 days after treatment.